FDA.reportPublic FDA data

YARGESA 100 MG Oral Capsule

RxCUI
2642350
RxNorm name
YARGESA 100 MG Oral Capsule
Display name
YARGESA 100 MG Oral Capsule
Full name
YARGESA 100 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YargesaMIGLUSTATEdenbridge Pharmaceuticals LLC.2b371dfe-e2b0-47fe-b677-a7bde7149f872025-12-17Warnings, Adverse reactionsExact identifier
rxcui: 2642350

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2b371dfe-e2b0-47fe-b677-a7bde7149f87YARGESA 100 MG Oral Capsule [PSN] · miglustat 100 MG Oral Capsule [Yargesa] [SBD] · Yargesa 100 MG Oral Capsule [SY]35These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 200320251217